(Not so) voluntary hospitalization as part of Zolpidem-induced complex sleep behaviour: a case report
Sriraksha R Nayak1, Suman S Rao2, Karthik K N2
1Department of Psychiatry, PES University Institute of Medical Sciences and Research, Electronic City, Bengaluru, 560100, Karnataka, India. srirakshanayak@gmail.com.
Background:
Since its approval 26 years ago, Zolpidem has been implicated in 61 cases of complex sleep behaviours (CSBs) reported to the US FDA. These cases typically describe activities such as eating, walking, cooking or driving while asleep after Zolpidem use. This report describes a unique presentation of Zolpidem-induced CSB.
Case Presentation:
A 44-year-old male with recurrent depressive disorder presented with a history of waking up in a hospital with no recollection of how he was admitted. He subsequently discharged himself against medical advice. In addition to his regular treatment, he had been prescribed Zolpidem on an as-needed basis for persistent insomnia. A thorough review of his past medical history with corresponding prescriptions revealed two similar instances in which he sought discharge against medical advice after waking up in a hospital with no recollection of how he was admitted. Each instance was temporally correlated with the use of Zolpidem.
Conclusions:
This case illustrates a rare presentation of Zolpidem-induced CSB, where the patient hired a cab to a psychiatric hospital, admitted himself and cooperated with inpatient management until regaining awareness the following morning. The patient experienced three similar episodes of Zolpidem-induced CSB, each resulting in voluntary psychiatric admission. Practitioners prescribing Z-drugs, either alone or in combination with other psychotropic medications, should be aware of these rare yet potentially serious adverse events and their forensic implications.
More Related Videos
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Related Concept Videos
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Management of Insomnia
CNS Depressants: Barbiturates and Benzodiazepines
REM Sleep Behavior Disorder
RBD is significantly associated with...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
